Ovarian Cancers: Evolving Paradigms in Research and Care


Despite recent promising advances in cancer research, there are still surprising gaps in the fundamental knowledge about ovarian cancer. Limitations in our understanding about the biology of the disease—and gaps in the evidence base to support diagnosis, delivery of care, and survivorship—impede efforts to improve the prevention, early detection, treatment, and ongoing care for women with ovarian cancer.

Ovarian cancer is relatively uncommon, yet it is one of the deadliest cancers. Each year in the United States, more than 21,000 women are diagnosed with ovarian cancer, and more

than 14,000 women die from the disease. Late diagnosis and a high recurrence rate contribute to the high mortality rate.

The Centers for Disease Control and Prevention (CDC) asked the National Academies of Sciences, Engineering, and Medicine to convene an expert committee to examine the state of the science in ovarian cancer research, identify major knowledge gaps about the biology and treatment of ovarian cancer, and consider opportunities to advance the research. Learn more on the next page.